Cuproptosis-associated genes (CAGs) contribute to the prognosis prediction and potential therapeutic targets in hepatocellular carcinoma

肝细胞癌 免疫系统 间质细胞 免疫疗法 肿瘤微环境 癌症研究 医学 肿瘤科 生物 免疫学
作者
Xiaoli Shi,Dongmin Shi,Yanping Yin,Yuzhang Wu,Wenwei Chen,Yue Yu,Xuehao Wang
出处
期刊:Cellular Signalling [Elsevier]
卷期号:117: 111072-111072
标识
DOI:10.1016/j.cellsig.2024.111072
摘要

Cuproptosis is a novel form of cell death that exhibits close association with mitochondrial respiration and occurs through distinct mechanisms compared to previously characterized forms of cell death. However, the precise impact of cuproptosis-associated genes (CAGs) on prognosis, immune profiles, and treatment efficacy in hepatocellular carcinomas (HCC) remains poorly understood.A comprehensive analysis of CAGs in hepatocellular carcinoma (HCC) prognosis was conducted using genomic data from HCC patients. Consensus clustering analysis was performed to determine molecular subtypes related to cuproptosis in HCC. The single-sample gene set enrichment analysis (ssGSEA) algorithm was applied to quantify the infiltration levels of immune cells, while the "ESTIMATE" package was employed to calculate tumor purity, stromal scores, and immune scores in the tumor microenvironment (TME). Principal component analysis (PCA) algorithm was utilized to construct a risk score related to CAGs. Finally, CCK8, wound healing, Transwell migration/invasion, EDU and xenograft model were employed to explore the potential oncogenic role of MTF1.Three distinct patterns of cuproptosis modification were identified, each associated with unique functional enrichments, clinical characteristics, immune cell infiltration, immune checkpoints, tumor microenvironment (TME), and prognosis. A CAGs-related risk score (Cuscore) was developed to predict prognosis in TCGA and validated in GSE76427 and ICGC datasets. Notably, patients with a low Cuscore had better prognoses and were more likely to benefit from immunotherapy.Additionally, the high Cuscore group in HCC also revealed three potential therapeutic targets (TUBA1B, CDC25B, and CSNK2A1) as well as several therapeutic compounds. Moreover, the experiment measured the expression levels of six prognosis-related CAGs, wherein knockdown of MTF1 exhibited suppression of proliferation, invasion, and migration formation in HCC cell lines.The findings have enhanced our comprehension of the cuproptosis characteristics in HCC, and stratification based on CuScore may potentially enhance the prediction of patients' prognosis and facilitate the development of effective and innovative treatment strategies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
laohu完成签到,获得积分10
刚刚
7秒前
司马懿完成签到 ,获得积分10
8秒前
小王子ydy完成签到 ,获得积分10
11秒前
调皮的蓝天完成签到 ,获得积分10
12秒前
Jonsnow完成签到 ,获得积分10
14秒前
大模型应助guojingjing采纳,获得10
17秒前
sunsun10086完成签到 ,获得积分10
18秒前
轩辕剑身完成签到,获得积分0
29秒前
40秒前
怡心亭完成签到 ,获得积分10
42秒前
qyyhappy完成签到 ,获得积分10
43秒前
夏纪完成签到 ,获得积分10
44秒前
44秒前
t铁核桃1985完成签到 ,获得积分10
49秒前
肉丸完成签到 ,获得积分10
49秒前
杨阳洋完成签到 ,获得积分10
51秒前
鲸鱼完成签到 ,获得积分10
51秒前
Garrett完成签到 ,获得积分10
52秒前
科研通AI2S应助guojingjing采纳,获得10
55秒前
称心的访彤完成签到 ,获得积分10
1分钟前
1分钟前
郑雅柔完成签到 ,获得积分10
1分钟前
guojingjing发布了新的文献求助10
1分钟前
Garrett完成签到 ,获得积分10
1分钟前
yinlu完成签到 ,获得积分10
1分钟前
默默小海豚完成签到 ,获得积分10
1分钟前
蒙古马完成签到 ,获得积分10
1分钟前
苏子轩完成签到 ,获得积分10
1分钟前
1分钟前
guojingjing发布了新的文献求助10
1分钟前
失眠的香蕉完成签到 ,获得积分10
1分钟前
LILILI完成签到 ,获得积分10
1分钟前
天才小能喵完成签到 ,获得积分10
1分钟前
没用的三轮完成签到,获得积分10
1分钟前
简单的战斗机完成签到,获得积分10
1分钟前
大模型应助科研通管家采纳,获得10
1分钟前
roundtree完成签到 ,获得积分0
1分钟前
1分钟前
1分钟前
高分求助中
Thermodynamic data for steelmaking 3000
Counseling With Immigrants, Refugees, and Their Families From Social Justice Perspectives pages 800
藍からはじまる蛍光性トリプタンスリン研究 400
Cardiology: Board and Certification Review 400
A History of the Global Economy 350
[Lambert-Eaton syndrome without calcium channel autoantibodies] 340
New Words, New Worlds: Reconceptualising Social and Cultural Geography 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2364960
求助须知:如何正确求助?哪些是违规求助? 2073658
关于积分的说明 5183935
捐赠科研通 1801237
什么是DOI,文献DOI怎么找? 899598
版权声明 557920
科研通“疑难数据库(出版商)”最低求助积分说明 480043